Plus   Neg

Abacus Health To Enter U.S. Convenience Store Market Segment

Abacus Health Products, Inc., a manufacturer of CBD-based topical pain-relief treatments, said it will enter the U.S. convenience store market segment through a distribution agreement with E&S International Enterprises, Inc. or ESI.

Canada-based Abacus Health manufactures and sells over-the-counter or OTC topical medications infused with cannabidiol or CBD extracted from hemp. The company currently offers two lines of products - CBD Clinic, marketed to the professional practitioner market, and CBDMedic, marketed to the consumer market.

Under the deal, ESI will distribute Abacus Health's topical pain relief and skincare product line, CBDMedic, to the convenience store channel from early 2020. ESI has a strong presence in the convenience store channel through the wholesale and distribution of consumer products.

Abacus Health said it has developed new form factors of CBDMedic that are specifically designed for the convenience store market.

"The convenience store channel represents over 150,000 locations across the United States and the distribution of our topical CBDMEDIC line of products is a natural extension in our efforts to offer our products to consumers across the United States," said Perry Antelman, CEO of Abacus Health.

Antelman added that he looked forward to seeing CBDMedic products on convenience store shelves in the U.S. in early 2020.

ESI distributes products, including appliances, housewares, sporting goods, toys and other general merchandise through various channels in the U.S., including digital platforms, TV shopping platforms, sporting goods and outdoor specialty stores. The company is also active in international distribution, primarily in Latin and South America.

Under the agreement with Abacus, ESI will pursue these additional channels in the U.S. as well as select countries in Latin and South America, in co-operation with Abacus.

The deal between Abacus and ESI will be in effect until either party terminates it, subject to a 180-day prior notice requirement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple chief executive officer Tim Cook condemned the killing of an unarmed black man, George Floyd, and called for the creation of a "better, more just world for everyone," according to reports citing a memo to employees. Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining.
Follow RTT